Skip to main content

Advertisement

Log in

Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery

  • Original Paper
  • Published:
Clinical Research in Cardiology Aims and scope Submit manuscript

Abstract

Background

The impact of obesity on the incidence of perioperative myocardial infarction/injury (PMI) and mortality following non-cardiac surgery is not well understood.

Methods

We performed a prospective diagnostic study enrolling consecutive patients undergoing non-cardiac surgery, who were considered at increased cardiovascular risk. All patients were screened for PMI, defined as an absolute increase from preoperative to postoperative sensitive/high-sensitivity cardiac troponin T (hs-cTnT) concentrations. The body mass index (BMI) was classified according to the WHO classification (underweight< 18 kg/m2, normal weight 18–24.9 kg/m2, overweight 25–29.9 kg/m2, obesity class I 30–34.9 kg/m2, obesity class II 35–39.9 kg/m2, obesity class III > 40 kg/m2). The incidence of PMI and all-cause mortality at 365 days, both stratified according to BMI.

Results

We enrolled 4277 patients who had undergone 5413 surgeries. The median BMI was 26 kg/m2 (interquartile range 23–30 kg/m2). Incidence of PMI showed a non-linear relationship with BMI and ranged from 12% (95% CI 9–14%) in obesity class I to 19% (95% CI 17–42%) in the underweight group. This was confirmed in multivariable analysis with obesity class I. showing the lowest risk (adjusted OR 0.64; 95% CI 0.49–0.83) for developing PMI. Mortality at 365 days was lower in all obesity groups compared to patients with normal body weight (e.g., unadjusted OR 0.54 (95% CI 0.39–0.73) and adjusted OR 0.52 (95% CI 0.38–0.71) in obesity class I).

Conclusion

Obesity class I was associated with a lower incidence of PMI, and obesity in general was associated with a lower all-cause mortality at 365 days.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4 

Similar content being viewed by others

Abbreviations

ASA:

American Society of Anesthesiologists

BMI:

Body mass index

CAD:

Coronary artery disease

CI:

Confidence interval

COPD:

Chronic obstructive pulmonary disease

ECG:

Electrocardiography

ESC:

European Society of Cardiology

ESA:

European Society of Anesthesiology

HR:

Hazard ratio

Hs-cTnT:

High-sensitivity cardiac troponin T

IQR:

Interquartile range

s-cTnI:

Sensitive cardiac troponin I

METS:

Metabolic equivalent

OR:

Odds ratio

PMI:

Perioperative myocardial injury

RCRI:

Revised Cardiac Risk Index

TIA:

Transient ischemic attack

TNF-α:

Tumor necrosis factor-α

WHO:

World Health Organization

References

  1. Data and statistics. 2019. https://www.euro.who.int/en/health-topics/noncommunicable-diseases/obesity/data-and-statistics. Accessed 27 Jan 2019

  2. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL (2018) Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007–2008 to 2015–2016. JAMA 319(16):1723–1725. https://doi.org/10.1001/jama.2018.3060

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ortega FB, Lavie CJ, Blair SN (2016) Obesity and cardiovascular disease. Circ Res 118(11):1752–1770. https://doi.org/10.1161/CIRCRESAHA.115.306883

    Article  CAS  PubMed  Google Scholar 

  4. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD (2003) Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63(3):793–808. https://doi.org/10.1046/J.1523-1755.2003.00803.X

    Article  PubMed  Google Scholar 

  5. Buettner HJ, Mueller C, Gick M et al (2007) The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 28(14):1694–1701. https://doi.org/10.1093/eurheartj/ehm220

    Article  PubMed  Google Scholar 

  6. Valentijn TM, Galal W, Tjeertes EKM, Hoeks SE, Verhagen HJ, Stolker RJ (2013) The obesity paradox in the surgical population. Surgeon 11(3):169–176. https://doi.org/10.1016/j.surge.2013.02.003

    Article  PubMed  Google Scholar 

  7. Puelacher C, Lurati Buse G, Seeberger D et al (2018) Perioperative myocardial injury after noncardiac surgery. Circulation 137(12):1221–1232. https://doi.org/10.1161/CIRCULATIONAHA.117.030114

    Article  PubMed  Google Scholar 

  8. Devereaux PJ, Biccard BM, Sigamani A et al (2017) Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA 317(16):1642. https://doi.org/10.1001/jama.2017.4360

    Article  CAS  PubMed  Google Scholar 

  9. Thygesen K, Alpert JS, Jaffe AS et al (2018) Fourth universal definition of myocardial infarction. Circulation. https://doi.org/10.1161/CIR.0000000000000617

    Article  PubMed  Google Scholar 

  10. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. PLoS Med 4(10):1623–1627. https://doi.org/10.1371/journal.pmed.0040296

    Article  Google Scholar 

  11. World Health Organization (2000) Obesity: preventing and managing the global epidemic: report of a WHO consultation. World Health Organization, Geneva

    Google Scholar 

  12. Kristensen SD, Knuuti J, Saraste A et al (2014) ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur J Anaesthesiol 31:517–573. https://doi.org/10.1097/EJA.0000000000000150

    Article  PubMed  Google Scholar 

  13. Lee TH, Marcantonio ER, Mangione CM et al (1999) Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. https://www.circulationaha.org. Accessed 27 Aug 2018

  14. Reichlin T, Hochholzer W, Bassetti S et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361(9):858–867. https://doi.org/10.1056/NEJMoa0900428

    Article  CAS  PubMed  Google Scholar 

  15. Twerenbold R, Boeddinghaus J, Nestelberger T et al (2017) Clinical use of high-sensitivity cardiac troponin in patients with suspected myocardial infarction. J Am Coll Cardiol 70(8):996–1012. https://doi.org/10.1016/J.JACC.2017.07.718

    Article  CAS  PubMed  Google Scholar 

  16. Wildi K, Nelles B, Twerenbold R et al (2016) Safety and efficacy of the 0 h/3 h protocol for rapid rule out of myocardial infarction. Am Heart J 181:16–25. https://doi.org/10.1016/J.AHJ.2016.07.013

    Article  PubMed  Google Scholar 

  17. Kavsak PA, MacRae AR, Yerna M-J, Jaffe AS (2009) Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin i assay for early detection of myocardial injury. Clin Chem 55(3):573–577. https://doi.org/10.1373/clinchem.2008.116020

    Article  CAS  PubMed  Google Scholar 

  18. Hicks KA, Tcheng JE, Bozkurt B et al (2015) 2014 ACC/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials. Circulation 132(4):302–361. https://doi.org/10.1161/CIR.0000000000000156

    Article  PubMed  Google Scholar 

  19. Agresti A, Coull BA (1998) Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 52(2):119–126. https://doi.org/10.1080/00031305.1998.10480550

    Article  Google Scholar 

  20. Bagley SC, White H, Golomb BA (2001) Logistic regression in the medical literature: standards for use and reporting, with particular attention to one medical domain. J Clin Epidemiol 54(10):979–985. https://doi.org/10.1016/s0895-4356(01)00372-9

    Article  CAS  PubMed  Google Scholar 

  21. Valentijn TM, Galal W, Hoeks SE, van Gestel YR, Verhagen HJ, Stolker RJ (2013) Impact of obesity on postoperative and long-term outcomes in a general surgery population: a retrospective cohort study. World J Surg 37(11):2561–2568. https://doi.org/10.1007/s00268-013-2162-y

    Article  PubMed  Google Scholar 

  22. Davenport DL, Xenos ES, Hosokawa P, Radford J, Henderson WG, Endean ED (2009) The influence of body mass index obesity status on vascular surgery 30-day morbidity and mortality. J Vasc Surg 49(1):140–147.e1. https://doi.org/10.1016/j.jvs.2008.08.052

    Article  PubMed  Google Scholar 

  23. Dindo D, Muller MK, Weber M, Clavien P-A (2003) Obesity in general elective surgery. Lancet 361(9374):2032–2035. https://doi.org/10.1016/S0140-6736(03)13640-9

    Article  PubMed  Google Scholar 

  24. Haslam DW, James WPT (2005) Obesity. Lancet 366(9492):1197–1209. https://doi.org/10.1016/S0140-6736(05)67483-1

    Article  PubMed  Google Scholar 

  25. Packer M (2018) Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium. J Am Coll Cardiol 71(20):2360–2372. https://doi.org/10.1016/J.JACC.2018.03.509

    Article  CAS  PubMed  Google Scholar 

  26. Hopkins T, Ouchi N, Shibata R, Walsh K (2007) Adiponectin actions in the cardiovascular system. Cardiovasc Res 74(1):11–18. https://doi.org/10.1016/j.cardiores.2006.10.009

    Article  CAS  PubMed  Google Scholar 

  27. Roman M, Monaghan A, Serraino GF et al (2019) Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes. BJS 106(3):181–189. https://doi.org/10.1002/bjs.11001

    Article  CAS  Google Scholar 

  28. Devereaux PJ, Duceppe E, Guyatt G et al (2018) Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet 391(10137):2325–2334. https://doi.org/10.1016/S0140-6736(18)30832-8

    Article  CAS  PubMed  Google Scholar 

  29. Suthahar N, Meijers WC, Ho JE et al (2018) Sex-specific associations of obesity and N-terminal pro-B-type natriuretic peptide levels in the general population. Eur J Heart Fail 20(8):1205–1214. https://doi.org/10.1002/ejhf.1209

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

Thomas Wolff: Division of Vascular Surgery, University Hospital Basel, University of Basel, Switzerland; Karin Wildi: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Alessandro Genini: Department of Anaesthesiology, University Hospital Basel, University of Basel, Switzerland; Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Raphael Twerenbold: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Lorraine Sazgary: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Luca Koechlin: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Desiree Wussler: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Tobias Breidthardt: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Dayana Flores: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Stefan Osswald: Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital of Basel, University of Basel, Switzerland; Katharina Rentsch: Department of Laboratory Medicine, University Hospital Basel, University of Basel, Switzerland.

Funding

This study was supported by research grants from the Swiss National Science Foundation, the Swiss Heart Foundation, the Stiftung Für Kardiovaskuläre Forschung Basel, the University of Basel, the University Hospital Basel, Abbott and Roche, Forschungsfond Kantonsspital Aarau.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Christian Puelacher.

Ethics declarations

Conflicts of interest

Mr. Christian Puelacher PhD, MD has received research support from Roche Diagnostic. Prof. Mueller has received research support from the Swiss National Science Foundation, the Swiss Heart Foundation, the European Union, the Kommission für Technologie & Innovation, the Stiftung für kardiovaskuläre Forschung Basel, the University of Basel, the University Hospital Basel, Abbott, Beckman Coulter, Biomerieux, Brahms, Idorsia, Novartis, Ortho Clinical Diagnostics, Quidel, Roche, Sanofi, Siemens, Singulex, Sphingotec, as well as speaker honoraria/consulting honoraria from Acon, Amgen, Astra Zeneca, Bayer, Biomerieux, Boehringer Ingelheim, BMS, Brahms, Novartis, Roche, Sanofi, Siemens, and Singulex. Dr. Twerenbold has received research support from the Swiss National Science Foundation (P300PB-167803_1), the Swiss Heart Foundation, the Swiss Society of Cardiology, the University Hospital Basel, and the Cardiovascular Research Foundation; and has received speaker honoraria/consulting honoraria from Abbott, Amgen, Brahms, Roche, Siemens, and Singulex. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 55 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hidvegi, R., Puelacher, C., Gualandro, D.M. et al. Obesity paradox and perioperative myocardial infarction/injury in non-cardiac surgery. Clin Res Cardiol 109, 1140–1147 (2020). https://doi.org/10.1007/s00392-020-01605-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00392-020-01605-0

Keywords

Navigation